Evidence map›Paper›PMID 26865366›Full record

ArticleScientific reports2016

Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons.

Jin Bo Tang, Ya Fang Wu, Yi Cao, Chuan Hao Chen, You Lang Zhou, Bella Avanessian, Masaru Shimada, Xiao Tian Wang, Paul Y Liu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 97 citations in OpenAlex.

  1. Use of a bioresorbable polylactide sheet (OrthoWrapBMC musculoskeletal disorders · 2025
    Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Investigation of the effects of umbilical cord-derived mesenchymal stem cells and curcumin on Achilles tendon healing - can they act synergistically?Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Jin Bo TangThe Hand Surgery Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Ya Fang WuThe Hand Surgery Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Yi CaoThe Hand Surgery Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Chuan Hao ChenThe Hand Surgery Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
You Lang ZhouThe Hand Surgery Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Bella AvanessianDepartment of Plastic Surgery, Rhode Island Hospital, The Alpert Medical School, Brown University, Providence, RI, USA.
Masaru ShimadaDepartment of Molecular Biodefense Research, Yokohama City University, Yokohama, Japan.
Xiao Tian WangDepartment of Plastic Surgery, Rhode Island Hospital, The Alpert Medical School, Brown University, Providence, RI, USA.
Paul Y LiuDepartment of Plastic Surgery, Rhode Island Hospital, The Alpert Medical School, Brown University, Providence, RI, USA.
Affiliated Hospital of Nantong University · CNBrown University · USNantong University · CNRhode Island Hospital · USYokohama City University · JP

Funding

WATER CHANNEL AQUAPORIN-3 IN BM-DERIVED EPIDERMAL CELLS PLAY ROLE WOUND HEALINGP20RR018757 · NCRR · ROGER WILLIAMS HOSPITAL · PI RODRIGUES, NEESHA · 2003 to 2011
$22.5M
NCRR NIH HHS P 20 RR018757NCRR NIH HHS P20 RR018757
6 · The paper itself

Abstract

Tendon injury during limb motion is common. Damaged tendons heal poorly and frequently undergo unpredictable ruptures or impaired motion due to insufficient innate healing capacity. By basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF) gene therapy via adeno-associated viral type-2 (AAV2) vector to produce supernormal amount of bFGF or VEGF intrinsically in the tendon, we effectively corrected the insufficiency of the tendon healing capacity. This therapeutic approach (1) resulted in substantial amelioration of the low growth factor activity with significant increases in bFGF or VEGF from weeks 4 to 6 in the treated tendons (p < 0.05 or p < 0.01), (2) significantly promoted production of type I collagen and other extracellular molecules (p < 0.01) and accelerated cellular proliferation, and (3) significantly increased tendon strength by 68-91% from week 2 after AAV2-bFGF treatment and by 82-210% from week 3 after AAV2-VEGF compared with that of the controls (p < 0.05 or p < 0.01). Moreover, the transgene expression dissipated after healing was complete. These findings show that the gene transfers provide an optimistic solution to the insufficiencies of the intrinsic healing capacity of the tendon and offers an effective therapeutic possibility for patients with tendon disunion.

Indexed as

AnimalsCell ProliferationChickensCollagen Type IDependovirusFibroblast Growth Factor 2FibronectinsGene Expression RegulationGenetic TherapyGenetic VectorsLamininPrimary Cell CultureTendon InjuriesTendonsTenocytesTensile StrengthCollagen Type IFibroblast Growth Factor 2FibronectinsLamininVascular Endothelial Growth Factor A

Identifiers

PMID26865366
PMCPMC4749961
OpenAlexW2442244161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.